Are advanced glycation end products cardiovascular risk factors in patients with CRF?

American Journal of Kidney Diseases

Volumn 41, Issue 3 SUPPL. 1, 2003, Pages

  Stein, Günter ^a   Busch, Martin ^b   Müller, Andreas ^b   Wendt, Thoralf ^b   Franke, Christiane ^b   Niwa, Toshimitsu ^b   Franke, Sybille ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b NONE

Author keywords

Advanced glycation end products (AGEs); Renal failure; Risk factors

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; IMIDAZOLE DERIVATIVE; PENTOSIDINE;

ADULT; AGED; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; STATISTICAL ANALYSIS;

EID: 0037374294     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50085     Document Type: Conference Paper

References (16)

1. Parfrey PS: Pathogenesis of cardiac disease in dialysis patients. Semin Dial 12:62-68, 1999
2. Parfrey PS, Foley RN: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10:1606-1615, 1999
3. Wheeler DC, Steiger J: Evolution and etiology of cardiovascular diseases in renal transplant recipients. Transplantation 70:SS41-SS45, 2000 (suppl 11)
4. Miyata T, Ishikawa S, Asahi K, et al: 2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: Role of glycoxidation and lipoxidation reactions in vascular tissue damage. FEBS Lett 445:202-206, 1999
5. Yoshida S, Yamada K, Hamaguchi K, et al: Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation: Clin Nephrol 49:273-280, 1998
6. Niwa T, Katsuzaki T, Miyazaki S, et al: Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest 99:1272-1280, 1997
7. Wells-Knecht KJ, Brinkmann E, Wells-Knecht MC, et al: New biomarkers of Maillard reaction damage to proteins. Nephrol Dial Transplant 11:S41-S47, 1996 (suppl 5)
8. Hayase F, Konishi Y, Kato H: Identification of the modified structure of arginine residues in proteins with 3-deoxyglucosone, a Maillard reaction intermediate. Biosci Biotech Biochem 59:1404-1411, 1995
9. Miyata T, Ueda Y, Shinzato T, et al: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7:1198-1206, 1996
10. Padwal R, Straus SE, McAlister FA: Cardiovascular risk factors and their effects on the decision to treat hypertension: Evidence based review. BMJ 322:977-980, 2001
11. Massy Z: Importance of homocysteine, lipoprotein(a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients. Nephrol Dial Transplant 15:S81-S91, 2000 (suppl 5)
12. Hörl W: Uremic toxins: New aspects. J Nephrol 13:S83-S88. 2000 (suppl 3)
13. Friedlander MA, Hricik DE: Optimizing end-stage renal disease therapy for patients with diabetes mellitus. Semin Nephrol 17:331-335, 1997
14. Stitt AW, He C. Friedman S, et al: Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: Relationship to tissue AGEs. Mol Med 3:617-627, 1997
15. Nakamura Y, Horii Y, Nishino T, et al: Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol 143:1649-1656, 1993
16. Yoshida S, Yamada K, Hamaguchi K, et al: Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation. Clin Nephrol 49:273-280, 1998